Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386910012> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4386910012 endingPage "39" @default.
- W4386910012 startingPage "33" @default.
- W4386910012 abstract "Bladder cancer (BC) is the most common malignant tumor of the urinary tract and the 11th most frequent cancer worldwide. BC is the 2nd most common cancer in Lebanon in men and women.After searching for patients records in the pathology and oncology database, we identified those who underwent a cystectomy between 2017 and 2019 in our hospital, Hotel Dieu de France - Beirut. We selected for the study the patients who have undergone a cystectomy for MIBC. We excluded patients who initially had a pelvic tumor, or a prostate cancer invading the bladder, and patients with absent medical record from the study. We also noted the gender of the patients, if they are smokers and the number of pack years at the time of diagnosis, as well as their age, the histological type of the tumor, its stage according to the TNM classification and its grade. We also noted whether neoadjuvant chemotherapy was taken by the study 's subjects.The total number of patients who met the inclusion and exclusion criteria was 38. The median age of the population was 66 (± 10) years and the median number of pack years at diagnosis was 60 (± 36). 79% of study 's patients were males and 21% were females. Regarding the tumor 's histological type, the urothelial type predominated with 92% while the remaining 8% were of the squamous type. Regarding treatment modalities, only 20% of patients in the study received neoadjuvant chemotherapy before cystectomy. 80% of patients underwent a cystectomy directly without neoadjuvant and/or adjuvant chemotherapy. No patient received adjuvant chemotherapy. Among the 7 patients, 2 patients (29%) presented a pathological complete response (pCR; equivalent to pT0N0M0). 14% had a pT3 stage post-neoadjuvant chemotherapy and 43% had a pT4 stage.We can note a reluctance of urologists at our institution to prescribe neoadjuvant chemotherapy. It would therefore be interesting to extend the study to the national level with a larger number of patients, as well as to evaluate survival in patients who received neoadjuvant chemotherapy, especially in those presenting a pCR. Our study can serve as a point of change in the practice of urologists in Lebanon regarding BC." @default.
- W4386910012 created "2023-09-22" @default.
- W4386910012 creator A5015524203 @default.
- W4386910012 creator A5020427831 @default.
- W4386910012 creator A5056568308 @default.
- W4386910012 creator A5073977284 @default.
- W4386910012 creator A5085058618 @default.
- W4386910012 date "2023-09-01" @default.
- W4386910012 modified "2023-09-28" @default.
- W4386910012 title "Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in a Lebanese experience: in all aspects." @default.
- W4386910012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37732525" @default.
- W4386910012 hasPublicationYear "2023" @default.
- W4386910012 type Work @default.
- W4386910012 citedByCount "0" @default.
- W4386910012 crossrefType "journal-article" @default.
- W4386910012 hasAuthorship W4386910012A5015524203 @default.
- W4386910012 hasAuthorship W4386910012A5020427831 @default.
- W4386910012 hasAuthorship W4386910012A5056568308 @default.
- W4386910012 hasAuthorship W4386910012A5073977284 @default.
- W4386910012 hasAuthorship W4386910012A5085058618 @default.
- W4386910012 hasConcept C121608353 @default.
- W4386910012 hasConcept C126322002 @default.
- W4386910012 hasConcept C126894567 @default.
- W4386910012 hasConcept C143998085 @default.
- W4386910012 hasConcept C146357865 @default.
- W4386910012 hasConcept C151730666 @default.
- W4386910012 hasConcept C2775910329 @default.
- W4386910012 hasConcept C2776694085 @default.
- W4386910012 hasConcept C2780352672 @default.
- W4386910012 hasConcept C71924100 @default.
- W4386910012 hasConcept C86803240 @default.
- W4386910012 hasConceptScore W4386910012C121608353 @default.
- W4386910012 hasConceptScore W4386910012C126322002 @default.
- W4386910012 hasConceptScore W4386910012C126894567 @default.
- W4386910012 hasConceptScore W4386910012C143998085 @default.
- W4386910012 hasConceptScore W4386910012C146357865 @default.
- W4386910012 hasConceptScore W4386910012C151730666 @default.
- W4386910012 hasConceptScore W4386910012C2775910329 @default.
- W4386910012 hasConceptScore W4386910012C2776694085 @default.
- W4386910012 hasConceptScore W4386910012C2780352672 @default.
- W4386910012 hasConceptScore W4386910012C71924100 @default.
- W4386910012 hasConceptScore W4386910012C86803240 @default.
- W4386910012 hasIssue "43" @default.
- W4386910012 hasLocation W43869100121 @default.
- W4386910012 hasOpenAccess W4386910012 @default.
- W4386910012 hasPrimaryLocation W43869100121 @default.
- W4386910012 hasRelatedWork W123182686 @default.
- W4386910012 hasRelatedWork W2022837219 @default.
- W4386910012 hasRelatedWork W2078477972 @default.
- W4386910012 hasRelatedWork W2603025253 @default.
- W4386910012 hasRelatedWork W2795614148 @default.
- W4386910012 hasRelatedWork W3032049527 @default.
- W4386910012 hasRelatedWork W3111145153 @default.
- W4386910012 hasRelatedWork W3129080622 @default.
- W4386910012 hasRelatedWork W4315628570 @default.
- W4386910012 hasRelatedWork W2118673085 @default.
- W4386910012 hasVolume "1" @default.
- W4386910012 isParatext "false" @default.
- W4386910012 isRetracted "false" @default.
- W4386910012 workType "article" @default.